FDA inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site): FDA inspection ending Aug 29, 2023
FDA inspection 1222323 · Voluntary Action Indicated (VAI) · Lianyungang
Key facts
| Inspection ID | 1222323 |
|---|---|
| Firm | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) |
| FEI number | 3003404148 |
| Address | Economic, Port Industry Area Yan Xin East Rd And Technological Development Zone |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Aug 29, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data